ClinicalTrials.Veeva

Menu

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Galderma logo

Galderma

Status

Completed

Conditions

Lip Augmentation and Correction of Perioral Rhytids

Treatments

Device: Restylane Silk with Lidocaine

Study type

Interventional

Funder types

Industry

Identifiers

NCT02703948
43USC1505

Details and patient eligibility

About

This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .

Enrollment

60 patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
  • Males or females, 22 years of age or older
  • Subjects seeking augmentation therapy for the lips.

Exclusion criteria

  • History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
  • Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Restylane Silk with Lidocaine
Other group
Treatment:
Device: Restylane Silk with Lidocaine

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems